Every Milliliter Matters: Maximizing yield in fill-finish
In aseptic manufacturing, product loss is inevitable. But when you’re working with high-value or small-batch therapies, every lost milliliter means fewer doses and higher per-unit costs that can stifle a clinical trial or cause issues with drug supply.
This whitepaper breaks down where product loss occurs throughout formulation, filtration, filling, and testing. We then offer practical strategies and highlight specialized equipment to optimize yield
What You’ll Learn
A stage-by-stage breakdown of where and why product is lost
How much can be saved, with a side-by-side comparison of baseline vs. optimized process yield
Steps a CDMO can take to maximize yield
A real-world case study from Argonaut Manufacturing Services achieving 99% theoretical yield in a 500-vial fill
Who Should Read This
This whitepaper was written for sponsors working with limited or high-value drug substance, teams preparing for clinical or commercial fill-finish, and anyone evaluating CDMOs on true yield performance.
This website uses cookies and similar technologies to support basic site functionality and help us understand how visitors use the site. We use analytics tools such as Google Analytics, to improve website performance and content.We do not sell personal information or use cookies for targeted advertising.You can accept all cookies, reject non-essential cookies, or adjust your preferences at any time. For more information, please review our privacy policy.
Essential cookies and services enable basic functions and are necessary for the proper functioning of the website.
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
